hypophosphatemia
Information
- Disease name
- hypophosphatemia
- Disease ID
- DOID:0050336
- Description
- "A phosphorus metabolism disease that is characterized by hypophosphatemia and the symptoms of osteomalacia including bone pain, skeletal deformities and osteoarthritis." [url:https\://en.wikipedia.org/wiki/Hypophosphatemia]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06112236 | Active, not recruiting | Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special Focus on Hypophosphatemia | February 17, 2023 | March 31, 2027 | |
| NCT00975000 | Completed | Phase 3 | Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients | December 3, 2009 | April 16, 2013 |
| NCT00688077 | Completed | N/A | FGF-23 Suppressibility by Calcitonin | May 2008 | |
| NCT05098249 | Completed | Phase 4 | Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia | November 11, 2021 | May 23, 2023 |
| NCT03489993 | Completed | FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP) | December 6, 2018 | December 23, 2020 | |
| NCT03529058 | Completed | Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU | November 26, 2017 | March 31, 2018 | |
| NCT03740802 | Completed | Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis | January 26, 2018 | April 9, 2018 | |
| NCT03581591 | Completed | Phase 3 | Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets | January 31, 2018 | December 6, 2019 |
| NCT06350955 | Not yet recruiting | Phase 4 | IV Iron-induced Hypophosphatemia After RYGB | May 2024 | June 2026 |
| NCT06344546 | Not yet recruiting | Metabolic Pathway Analysis in Intensive Care Unit Patients With Refeeding Syndrome | April 2024 | June 2024 | |
| NCT05909722 | Recruiting | Validation of the GIDS and Description of Phosphate Disorders | January 8, 2024 | December 20, 2024 | |
| NCT03771105 | Suspended | Early Phase 1 | The Impact of Phosphate Metabolism on Healthy Aging | January 1, 2019 | August 2024 |
| NCT01011114 | Terminated | N/A | Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant | November 2009 | October 15, 2015 |
| NCT04814641 | Unknown status | Hypophosphatemia and Bronchiolitis | March 21, 2021 | June 2021 | |
| NCT01660308 | Unknown status | Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia | June 2011 | August 2016 | |
| NCT03976440 | Unknown status | Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED: a Pilot Study | June 1, 2019 | January 31, 2021 | |
| NCT04502784 | Unknown status | Investigation of Hypophosphataemia Following Intravenous Iron | October 7, 2019 | December 31, 2020 | |
| NCT04519762 | Unknown status | Phase 4 | Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU | September 15, 2020 | December 15, 2020 |
| NCT02837523 | Withdrawn | Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis) | August 20, 2018 | August 31, 2021 |
- Disase is a (Disease Ontology)
- DOID:2485
- Cross Reference ID (Disease Ontology)
- MESH:D017674
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002148
- MedGen concept unique identifier (MedGen Concept name)
- C0085682
- MedGen unique identifier (MedGen Concept name)
- 39327
- MeSH unique ID (MeSH (Medical Subject Headings))
- D017674